Tobias Keck
University Medical Center Schleswig Holstein
Appearances
PATIENT-REPORTED OUTCOMES AT THREE MONTHS AFTER PANCREATIC SURGERY FOR BENIGN AND MALIGNANT DISEASES
DateMay 19, 2024Background: Pancreatic surgery involves complex operative procedures and may have a long-lasting effect on patients’ health status and quality of life. Large-scale studies on patient-reported outcomes in patients after pancreatic procedures are warranted…Presenter
Speakers
University Medical Center Schleswig HolsteinMassachusetts General Hospital- DateMay 21, 2024Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer deaths with a survival rate of less than 11%. A prominent feature of PDAC is its highly desmoplastic reaction, characterized by an abundance of extracellular matrix (ECM) in primary and metastatic tumors…
Presenter
Speakers
Universitatsklinikum Schleswig Holstein - Campus LubeckUniversity Medical Center Schleswig Holstein - DateMay 21, 2024Background: Ampullary adenocarcinoma (AMPAC) are a rare entity of gastrointestinal malignancies arising from the Ampulla of Vater. Together with distal cholangiocarcinoma (DCC) and duodenal adenocarcinoma (DUOAC) AMPAC form the group of periampullary tumors…
Presenter
Massachusetts General HospitalSpeakers
Massachusetts General HospitalUniversity Medical Center Schleswig Holstein 
DateMay 6, 2025SOCIETY: SSATModerators
Baylor University Medical Center at DallasUniversity Medical Center Schleswig HolsteinUniversity of Miami
